These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 10845431

  • 21. Clinical comparison of cefuroxime axetil suspension and amoxicillin/clavulanate suspension in the treatment of pediatric patients with acute otitis media with effusion.
    Gooch WM, Blair E, Puopolo A, Paster Z, Schwartz RH, Miller HC, Smyre HL, Giguere GC, Collins JJ.
    Clin Ther; 1995; 17(5):838-51. PubMed ID: 8595636
    [Abstract] [Full Text] [Related]

  • 22. Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
    Chodosh S, McCarty J, Farkas S, Drehobl M, Tosiello R, Shan M, Aneiro L, Kowalsky S.
    Clin Infect Dis; 1998 Oct; 27(4):722-9. PubMed ID: 9798024
    [Abstract] [Full Text] [Related]

  • 23. A randomized study of sequential intravenous/oral moxifloxacin in comparison to sequential intravenous ceftriaxone/oral cefuroxime axetil in patients with hospital-acquired pneumonia.
    Höffken G, Barth J, Rubinstein E, Beckmann H, HAP study group.
    Infection; 2007 Dec; 35(6):414-20. PubMed ID: 18034211
    [Abstract] [Full Text] [Related]

  • 24. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA, Mathew CP, Warner JH, Heyd A, Church D.
    Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
    [Abstract] [Full Text] [Related]

  • 25. Clinical Comparison of Cefuroxime Axetil with Cefixime in the Treatment of Acute Bronchitis.
    Arthur M, McAdoo M, Guerra J, Maloney R, McCluskey D, Giguere G, Gomez G, Collins JJ.
    Am J Ther; 1996 Sep; 3(9):622-629. PubMed ID: 11862302
    [Abstract] [Full Text] [Related]

  • 26. Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis.
    Weiss LR.
    Clin Ther; 2002 Sep; 24(9):1414-25. PubMed ID: 12380633
    [Abstract] [Full Text] [Related]

  • 27. Moxifloxacin.
    Balfour JA, Wiseman LR.
    Drugs; 1999 Mar; 57(3):363-73; discussion 374. PubMed ID: 10193688
    [Abstract] [Full Text] [Related]

  • 28. Cefuroxime axetil: an updated review of its use in the management of bacterial infections.
    Scott LJ, Ormrod D, Goa KL.
    Drugs; 2001 Mar; 61(10):1455-500. PubMed ID: 11558834
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia.
    Higuera F, Hidalgo H, Feris J, Giguere G, Collins JJ.
    J Antimicrob Chemother; 1996 Mar; 37(3):555-64. PubMed ID: 9182112
    [Abstract] [Full Text] [Related]

  • 31. Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections.
    Balfour JA, Lamb HM.
    Drugs; 2000 Jan; 59(1):115-39. PubMed ID: 10718103
    [Abstract] [Full Text] [Related]

  • 32. Cefuroxime axetil in the treatment of acute sinusitis in childhood.
    Gürses N, Kalayci AG, Islek I, Uysal S.
    J Antimicrob Chemother; 1996 Sep; 38(3):547-50. PubMed ID: 8889729
    [Abstract] [Full Text] [Related]

  • 33. [Amoxycillin-clavulanic acid and cefuroxime axetil in the treatment of acute sinusitis. A clinical, radiological and bacteriological evaluation].
    Olmo A, Sabater F, Broto J, Traserra J.
    Acta Otorrinolaringol Esp; 1994 Sep; 45(1):25-9. PubMed ID: 8204290
    [Abstract] [Full Text] [Related]

  • 34. Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil.
    Alvarez-Sala JL, Kardos P, Martínez-Beltrán J, Coronel P, Aguilar L.
    Antimicrob Agents Chemother; 2006 May; 50(5):1762-7. PubMed ID: 16641447
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of ten day moxifloxacin 400 mg once daily in the treatment of patients with community-acquired pneumonia. Community Acquired Pneumonia Study Group.
    Patel T, Pearl J, Williams J, Haverstock D, Church D.
    Respir Med; 2000 Feb; 94(2):97-105. PubMed ID: 10714413
    [Abstract] [Full Text] [Related]

  • 36. Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis.
    Wilson R, Allegra L, Huchon G, Izquierdo JL, Jones P, Schaberg T, Sagnier PP, MOSAIC Study Group.
    Chest; 2004 Mar; 125(3):953-64. PubMed ID: 15006954
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A comparison of the efficacy of telithromycin versus cefuroxime axetil in the treatment of acute bacterial maxillary sinusitis.
    Buchanan PP, Stephens TA, Leroy B.
    Am J Rhinol; 2003 Mar; 17(6):369-77. PubMed ID: 14750614
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.